ArticleScientific reports2025
Integrative transcriptomic analysis identifies shared EndMT-related gene signatures in endometriosis and recurrent miscarriage.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Endometriosis (EMs) and recurrent miscarriage (RM) represent major reproductive health challenges. This study investigates the involvement of endothelial-mesenchymal transition (EndMT) in these conditions through integrative bioinformatics analysis, focusing on the dysregulation of EndMT-related genes (EndMTRGs). Transcriptomic datasets of EMs and RM were retrieved from the gene expression omnibus (GEO) database. Specifically, GSE120103 includes 18 endometriosis and 18 control samples, and GSE165004 includes 24 recurrent miscarriage and 24 control samples. Differentially expressed gene (DEG) analysis and EndMTRG profiling were performed to identify key pathways and hub genes associated with EndMT. Functional enrichment analyses, including gene ontology (GO), Kyoto encyclopedia of genes and genomes (KEGG), and gene set enrichment analysis (GSEA), were conducted. A protein-protein interaction (PPI) network was constructed via the STRING database, and hub genes were identified using cytoHubba algorithms. Immune cell infiltration patterns were evaluated through single-sample GSEA (ssGSEA). Additionally, support vector machine recursive feature elimination (SVM-RFE) was applied as a supplementary method to assist key gene selection, and nomograms were developed for preliminary risk prediction modeling. A total of 13 EndMTRGs were identified, with key genes such as FGF2, ITGB1, VIM, NR4A1, MAPK1, SMAD1, TUBB3, and CDH11 validated across external datasets. ROC curve analysis demonstrated high diagnostic performance of these genes. Regulatory networks involving RNA-binding proteins and transcription factors were delineated. Immune cell-related gene set enrichment analysis (ssGSEA) revealed distinct immune signatures, notably involving gamma-delta T (γδ T) cells and monocytes in EMs, and T follicular helper (Tfh) cells and natural killer (NK) cells in RM. Nomograms based on key genes exhibited reasonable predictive performance. This study elucidates the dysregulated EndMT landscape shared by endometriosis and recurrent miscarriage, identifying common gene signatures and immune features. These findings provide molecular insights into the shared pathogenesis of these conditions and highlight potential targets for future translational research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.